Healthcare provider profile · identity verified

Ann Degroff Carter, MD

Family Practice · KNOXVILLE, TN · NPI 1417946674

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	263	55
Mirtazapine	Mirtazapine	194	43
Eliquis	Apixaban	185	43
Amlodipine Besylate	Amlodipine Besylate	175	36
Quetiapine Fumarate	Quetiapine Fumarate	167	22
Levothyroxine Sodium	Levothyroxine Sodium	164	38
Tamsulosin Hcl	Tamsulosin Hcl	139	26
Furosemide	Furosemide	132	28
Lisinopril	Lisinopril	129	26
Levetiracetam	Levetiracetam	125	14
Metoprolol Tartrate	Metoprolol Tartrate	122	22
Buspirone Hcl	Buspirone Hcl	117	41
Potassium Chloride	Potassium Chloride	112	17
Carvedilol	Carvedilol	102	19
Sertraline Hcl	Sertraline Hcl	95	18
Escitalopram Oxalate	Escitalopram Oxalate	92	21
Trazodone Hcl	Trazodone Hcl	92	17
Donepezil Hcl	Donepezil Hcl	83	16
Clopidogrel	Clopidogrel Bisulfate	74	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	18
Gabapentin	Gabapentin	70	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	26
Baclofen	Baclofen	68	suppressed
Ondansetron Hcl	Ondansetron Hcl	67	30
Metformin Hcl	Metformin Hcl	64	13
Pantoprazole Sodium	Pantoprazole Sodium	63	28
Hydralazine Hcl	Hydralazine Hcl	62	18
Risperidone	Risperidone	62	suppressed
Losartan Potassium	Losartan Potassium	61	11
Pravastatin Sodium	Pravastatin Sodium	60	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	suppressed
Bumetanide	Bumetanide	56	22
Latanoprost	Latanoprost	48	suppressed
Famotidine	Famotidine	47	14
Aripiprazole	Aripiprazole	45	suppressed
Lactulose	Lactulose	45	11
Jardiance	Empagliflozin	44	suppressed
Spironolactone	Spironolactone	44	suppressed
Mupirocin	Mupirocin	43	25
Metoprolol Succinate	Metoprolol Succinate	42	12
Nystop	Nystatin	42	28
Finasteride	Finasteride	41	suppressed
Oxycodone Hcl	Oxycodone Hcl	41	21
Prednisone	Prednisone	39	25
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	36	21
Divalproex Sodium	Divalproex Sodium	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	20
Insulin Lispro Kwikpen U-100	Insulin Lispro	32	14
Lamotrigine	Lamotrigine	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	23
Atenolol	Atenolol	31	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Allopurinol	Allopurinol	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Mirabegron Er	Mirabegron	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Haloperidol	Haloperidol	26	suppressed
Omeprazole	Omeprazole	25	13
Myrbetriq	Mirabegron	24	suppressed
Breyna	Budesonide/Formoterol Fumarate	23	suppressed
Cefdinir	Cefdinir	23	18
Trintellix	Vortioxetine Hydrobromide	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Nateglinide	Nateglinide	22	suppressed
Digoxin	Digoxin	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Cephalexin	Cephalexin	19	11
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	19	suppressed
Restasis Multidose	Cyclosporine	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Anastrozole	Anastrozole	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Levofloxacin	Levofloxacin	15	11
Metformin Hcl Er	Metformin Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Haloperidol Lactate	Haloperidol Lactate	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Fluconazole	Fluconazole	13	11
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Budesonide	Budesonide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Gemtesa	Vibegron	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error